[1]JournalofMedicinalChemistry,1974,vol.17,p.1177-1181
[1]Heterocycles,2018,vol.96,p.509-517
[2]IlFarmaco,1999,vol.54,p.533-541
[3]RSCAdvances,2018,vol.8,p.170-175
[4]ChemicalandPharmaceuticalBulletin,2005,vol.53,p.410-418
[5]CanadianJournalofChemistry,1977,vol.55,p.2331-2335
[6]JournalofHeterocyclicChemistry,1980,vol.17,p.819-821
[7]Patent:WO2011/109799,2011,A1.Locationinpatent:Page/Pagecolumn171
[8]JournaloftheAmericanChemicalSociety,2015,vol.137,p.5670-5673
[9]MedicinalChemistryResearch,2016,vol.25,p.2399-2409
[10]OrganicandBiomolecularChemistry,2019,vol.17,p.7664-7668
[1]JournalofMedicinalChemistry,1974,vol.17,p.1177-1181
[1]EuropeanJournalofMedicinalChemistry,2017,vol.138,p.458-479
[2]EuropeanJournalofMedicinalChemistry,2019,vol.164,p.352-365
[3]JustusLiebigsAnnalenderChemie,1974,p.1195-1205
[4]BioorganicChemistry,2021,vol.114
[1]IlFarmaco,1999,vol.54,p.533-541
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: 3-Methyl-thio-benzamide.
Journal: Acta crystallographica. Section E, Structure reports online 20090601